Australia; NSW
Less than 5 per cent of reports to the Therapeutic Goods Administration about adverse drug reactions come from doctors, and voluntary reporting of these events is in decline, according to Australian experts. In Australia, it is mandatory for pharmaceutical companies to report all serious adverse events suspected of being related to their drugs, but reporting by health professionals has always been voluntary. The authors say without robust reporting mechanisms supporting the detection of safety signals, rare adverse drug events may remain undetected for years, exposing patients to unanticipated risks. The authors say an Australian committee could be reinstated to raise the profile of drug safety in Australia.
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Sign In
